Home » Topics » Articles » Insight

Insight
RSS

Week in review

June 17, 2019

Word on the street

June 17, 2019

Week in Washington

June 17, 2019

Phase I clinical trials: May 2019

June 17, 2019

Phase II clinical trials: May 2019

June 17, 2019

Public financing of biotechnology companies: Commenced trading in May 2019

June 10, 2019

Public financing of biotechnology companies: Filed and pending IPOs in May 2019

June 10, 2019

Other financings of public biotechnology companies in May 2019

June 10, 2019

Venture capital and other investments in private biotech companies in May 2019

June 10, 2019

BioWorld Stock Index 2019

June 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.